相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An overview of the extra-lipid effects of rosuvastatin
Michael S. Kostapanos et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome
Esther M. M. Ooi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells
Shucun Qin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Dose-dependent effect of rosuvastatin treatment on urinary protein excretion
Michael S. Kostapanos et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2
Vasilios G. Saougos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol
S. C. Bergheanu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
HDL cholesterol: Physiology, pathophysiology, and management
Jeffrey J. Link et al.
CURRENT PROBLEMS IN CARDIOLOGY (2007)
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia
Mihalis Kalogirou et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins
Bela F. Asztalos et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Antiatherogenic small, dense HDL - guardian angel of the arterial wall?
A Kontush et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)
Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma
I Gazi et al.
CLINICAL CHEMISTRY (2005)
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux
BF Asztalos et al.
JOURNAL OF LIPID RESEARCH (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C
MJ Chapman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity
AP Tambaki et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2004)
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase - Implication for atherosclerosis
M Eisaf et al.
BIOCHEMICAL PHARMACOLOGY (2003)
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity
AI Kakafika et al.
JOURNAL OF LIPID RESEARCH (2003)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Change in α1 HDL concentration predicts progression in coronary artery stenosis
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Paraoxonase and coronary heart disease
MI Mackness et al.
ATHEROSCLEROSIS SUPPLEMENTS (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients
BF Asztalos et al.
ATHEROSCLEROSIS (2002)
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
BF Asztalos et al.
JOURNAL OF LIPID RESEARCH (2002)
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB
V Tsimihodimos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
分享论文
